Brett Wingeier has over two decades of experience in the neuromodulation industry. He is the Co-Founder and Chief Technology Officer of Magnus Medical, a medical device company developing brain stimulation technologies to treat people suffering from clinical depression. He was previously the CEO and Co-Founder of Halo Neuroscience, a company which developed applications of transcranial direct current stimulation (tDCS), a form of brain stimulation, to enhance cognitive performance in sports. Brett is trained as a Biomedical Engineer, and has invented numerous devices aimed at neuromodulation. He holds 60+ US patents.